Scientific Advisory Board

Gunnar Kaufmann, Ph.D.

Chief Scientific Officer at Oncternal Therapeutics, Inc., and Adjunct Assistant Professor in the Dept of Chemistry and Immunology and Microbial Science at The Scripps Research Institute

Karl-Johan Malmberg, M.D., Ph.D.

Professor, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital.

James Mulé, Ph.D.

Associate Center Director for Translational Science, McGillicuddy Endowed Chair in Melanoma Research/Treatment, and Scientific Director of Cell-based Therapies at Moffitt Cancer Center.

Adel Nada, M.D., M.S., MFPM

Founding CEO of GentiBio, Inc., and former Chief Medical Officer, Casebia Therapeutics, a joint venture launched by Bayer and CRISPR Therapeutics.